|تاریخ چاپ: 1399/04/24|
|Effect of Estradiol on miR-21& miR-155 Expression in promyelocytic leukemia-derived cell line NB4|
|Author(s):||Robab Naghibzadeh، Narges Obeidi*، Alireza Farsinejd، Gholamreza Khamisipour، Masoud Tohid Far|
Due to the estrogen participation in modulating the proliferation and commitment of stem cells and the effects of miR-21 and miR-155 expression on reduced proliferation and colony formation of acute myeloid leukemia (AML), the aim of the present study was to evaluate the effect of estradiol on expression of miR-21 and miR-155 in the NB4 cell line, as an acute promyelocytic leukemia (APL).
Materials and Methods
In the present experiment, NB4 cells were treated with different quantities of estradiol (5, 25, 50, 75, 100, 150, 200, 250 μg/ml) and vehicle control for 24 and 48 hours. Viability, apoptosis, and cellular proliferation were estimated by trypan blue exclusion, flow cytometry, and MTT assays, respectively. The level of miR-155 and miR-21 expression was studied using absolute quantitative real-time PCR.
Results showed that estradiol in the effective dose (200 μg/ml) led to decreased cellular viability (in a dose dependent manner, P = 0.004) and apoptosis of NB4 cells. In addition, the expressions of miR-155 and miR-21 were significantly and dose-dependently decreased (p<0.05).
Estradiol at the effective dose caused apoptosis in NB4 cell line. This substance can be used as a drug for the treatment of APL. However, further assessments are needed to support the effectiveness of estradiol in the treatment of APL.
|Keywords:||cute Myeloid Leukemia (AML)، Estradiol، MiR-155، MiR-21|
|Article Type:||Research/Original Article|
|Published:||Iranian Journal of Pediatric Hematology and Oncology, Volume:10 Issue: 1, 2020|
|Full text:||PDF is available on the website.|